Home›Students›Undergraduate ECTS›Euro-MidLife
Students · Undergraduate ECTS elective 2027
Euro-MidLife
A blended intensive elective with four weeks of live webinars and one week on campus in Georgia, taught inside the elective curriculum of a partner medical school.
Award
Educational Achievement
Awarded by the host medical school
Credit
4 ECTS
30 hours of student work per credit
Format
4 + 1 weeks
Live webinars, then a week on campus
Dates
March–April 2027
Proposed, subject to university confirmation
Access
Via your school
Enrolment is through the partner school
1 · Who it is for
Undergraduate medical students in the clinical years
For students of a partner medical school whose elective curriculum includes the module. Enrolment is through the school; the page lists the deliveries and their dates.
2 · Level
FHEQ level 7 (equivalent to EQF level 7). The elective contains no level 8 content.
3 · Coverage
Whole syllabus: the eight webinars, the campus week and the capstone are taught in full in every delivery. 22 hours of the taught programme are European Union policy teaching.
Access for enrolled students
Enrolled students reach the course on the learning platform at learn.mdacumen.com by passwordless sign-in with the e-mail address given at enrolment.
4 · The award
Certificate of Educational Achievement; 4 ECTS credits; awarded by the host medical school (a partner medical school in Tbilisi, Georgia). New Vision University is not a UK degree-awarding body; recognition of credit is at the discretion of receiving institutions. (Spring 2027)
The credit is awarded by the host medical school; ECTS credit is decided by that school alone.
5 · Course Director and signer
Prof Rajesh Varma, PhD — NHS GP Partner and GP Trainer; Convenor for GP Trainers, West Hertfordshire; Vice Chair, RCGP Bedfordshire & Hertfordshire Faculty; Professor, New Vision University; Professor, East-West University; Visiting Researcher, Department of Public Health and Primary Care, University of Cambridge; Member, NICE Guideline Committee; Director, MD Acumen Ltd
Programme lead and clinical signer. Every clinical statement is signed by a named GMC-registered clinician with the date and the guideline version relied on. Nothing reaches a learner unsigned. AI assists the drafting of our material, and no AI decides a mark.
- Signed
- Prof Rajesh Varma · GMC 4196453
- Date
- Signed before each delivery · the references are listed below
- Review by
The course
Euro-MidLife
Euro-MidLife is a blended intensive elective on Midlife Medicine — the mid-life transition in women and men — organised in six pillars: menopause (with osteoporosis prevention); andropause; early-stage cardiovascular-kidney-metabolic syndrome (CKM stages 0 to 3, including thyroid disease); psychological midlife change; cancer screening; and evidence-based longevity. It is taught through European health policy and through European policy on inequality, data and artificial intelligence. The programme is proposed, subject to university confirmation.
Proposed for March–April 2027, subject to university confirmation. Eight joint webinars are followed by one on-campus week.
4 ECTS · Proposed · Spring 2027
Euro-MidLife
Euro-MidLife
Live webinars: Tue 16 Mar – Sat 10 Apr 2027, Tuesdays and Saturdays. On campus in Georgia: Mon 12 – Fri 16 Apr 2027 or Mon 19 – Fri 23 Apr 2027. Workload: 120 hours (4 × 30 h). Host: a partner medical school in Tbilisi, Georgia.
Learning outcomes
- Explain the Union’s competence and instruments in health, and evaluate how each bears on health disparities, artificial intelligence in healthcare and equity in health governance for mid-life health.
- Explain the endocrinology of the mid-life transition in women and men, and distinguish physiological ageing from pathological decline, as the cited guidelines set it out.
- Apply the Golden Triangle to a mid-life condition, and appraise the evidence for longevity interventions, distinguishing guideline-endorsed interventions from unproven claims.
- Construct a policy-aware, multidisciplinary triage and management plan for a complex mid-life presentation, justified by guideline and version.
- Construct and defend an original, policy-informed case analysis, declaring any use of AI tools.
7 · The Golden Triangle of its headline conditions
Where each condition stands today
Fixed to the condition and re-examined when its knowledge, evidence or real-world sources change. How the triangle works
Golden Triangle
Menopause and perimenopause, including premature ovarian insufficiency
Knowledge Green · Evidence Green · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 7 October 2026 · How the triangle works
Golden Triangle
Osteoporosis and fragility fracture risk
Knowledge Amber · Evidence Amber · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 8 October 2026 · How the triangle works
Golden Triangle
Male testosterone deficiency (late-onset hypogonadism)
Knowledge Amber · Evidence Amber · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 8 October 2026 · How the triangle works
Golden Triangle
Obesity
Knowledge Green · Evidence Green · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 7 October 2026 · How the triangle works
Golden Triangle
Neurodivergence (ADHD and autism) becoming visible in the perimenopause
Knowledge Amber · Evidence Red · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 8 October 2026 · How the triangle works
Golden Triangle
Cancer: delayed presentation and diagnosis (red-flag recognition and referral)
Knowledge Amber · Evidence Amber · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 7 October 2026 · How the triangle works
4 ECTS · Proposed · Spring 2027
Euro-MidLife · 4 ECTS · March–April 2027
Proposed dates for March–April 2027, subject to university confirmation. Live webinars Tue 16 Mar – Sat 10 Apr 2027 (Tuesdays and Saturdays, 07:00–09:30 UK time; the Georgia time of each session is shown in the table); on campus Mon 12 – Fri 16 Apr 2027 or Mon 19 – Fri 23 Apr 2027. Workload 120 hours: 42 h taught, 4 h examinations, 74 h independent study; 22 h of the taught programme is European Union policy teaching. Up to 30 students.
| Unit | Date · Georgia time · UK time | Session |
|---|---|---|
| Webinar 1 | Tue 16 Mar 2027 11:00–13:30 Georgia 07:00–09:30 GMT | The mid-life transition: menopause and the European policy landscape Tuesday session (2.5 h): European policy lecture (1.5 h) and clinical seminar (1 h). Formative quiz (not graded). |
| Webinar 2 | Sat 20 Mar 2027 11:00–13:30 Georgia 07:00–09:30 GMT | Menopause therapeutics and osteoporosis prevention Saturday session (2.5 h): European policy (1 h) and clinical workshop (1.5 h). Formative quiz (not graded). |
| Webinar 3 | Tue 23 Mar 2027 11:00–13:30 Georgia 07:00–09:30 GMT | Andropause: late-onset hypogonadism and the health of men Tuesday session (2.5 h): European policy lecture (1.5 h) and clinical seminar (1 h). Formative quiz (not graded). |
| Webinar 4 | Sat 27 Mar 2027 11:00–13:30 Georgia 07:00–09:30 GMT | Early-stage cardiovascular-kidney-metabolic syndrome I: weight gain, insulin resistance and thyroid disease Saturday session (2.5 h): European policy (1 h) and clinical workshop (1.5 h). Formative quiz (not graded). |
| Webinar 5 | Tue 30 Mar 2027 10:00–12:30 Georgia 07:00–09:30 BST | Early-stage CKM syndrome II: hypertension, dyslipidaemia, chronic kidney disease and health disparities across Europe Tuesday session (2.5 h): European policy lecture (1.5 h) and clinical seminar (1 h). Formative quiz (not graded). |
| Webinar 6 | Sat 3 Apr 2027 10:00–12:30 Georgia 07:00–09:30 BST | Psychological midlife change: burnout, sleep, mood, brain fog and neurodivergence unmasking Saturday session (2.5 h): European policy (1.5 h) and clinical content (1 h). Formative quiz (not graded). |
| Webinar 7 | Tue 6 Apr 2027 10:00–12:30 Georgia 07:00–09:30 BST | Cancer screening in mid-life: programmes, shared decisions and optional testing Tuesday session (2.5 h): European policy lecture (1.5 h) and clinical seminar (1 h). Formative quiz (not graded). |
| Webinar 8 | Sat 10 Apr 2027 10:00–12:30 Georgia 07:00–09:30 BST | Evidence-based longevity: appraising pharmacotherapy and the claims market Saturday session (2.5 h): European policy (1 h) and appraisal workshop (1.5 h). Formative quiz (not graded). |
| Exam | Mon 12 Apr 2027 Morning · time and room to be confirmed | Interim examination In person at the Examination Centre: 40 single-best-answer items, 60 minutes. 60 points. |
| Campus | Mon 12 Apr 2027 Local campus hours UK = Georgia − 3 h | Interim examination, then longevity II Interim examination (1 h), then a policy lecture (2 h) and a clinical practical (2.5 h): nutrition, gut microbiota and micronutrients. Repeated the following Monday. |
| Campus | Tue 13 Apr 2027 Local campus hours UK = Georgia − 3 h | Longevity III Policy lecture (2 h) and clinical practical (2.5 h): physical therapy interventions. Repeated the following Tuesday. |
| Deadline | Wed 14 Apr 2027 12:00 Georgia | Written capstone project 2,000 words; 5–10 references in Vancouver style; up to 4 tables and 4 figures. Submitted on the learning platform. |
| Campus | Wed 14 Apr 2027 Local campus hours UK = Georgia − 3 h | Multidisciplinary triage; written capstone due Policy lecture (2 h) and a simulated multidisciplinary clinic (2.5 h). Written capstone due by 12:00. Repeated the following Wednesday. |
| Campus | Thu 15 Apr 2027 Local campus hours UK = Georgia − 3 h | The host country and the Union; capstone coaching Policy lecture (2 h) and capstone coaching (2.5 h). Repeated the following Thursday. |
| Campus | Fri 16 Apr 2027 Local campus hours UK = Georgia − 3 h | Capstone lecture, benchmarking workshop and oral defences Capstone lecture (2 h), European benchmarking workshop (2 h) and oral defences (3 h, two parallel panels). Repeated the following Friday. |
Course structure
Eight webinars, one integration week
1 · Webinars 1–8 · online
Six pillars in eight sessions
Menopause with osteoporosis prevention; andropause; early-stage CKM syndrome; psychological midlife change; cancer screening; evidence-based longevity. Tuesday and Saturday sessions of 2.5 hours, each with a formative quiz.
2 · Interim examination
Monday of the campus week
One hour, single-best-answer, at the university’s Examination Centre, before campus teaching begins.
3 · On-campus week · Georgia
Integration and the capstone project
Longevity practicals, a simulated multidisciplinary clinic, the host country and the Union, capstone coaching; the written capstone due on the Wednesday; the capstone lecture and oral defences on the Friday.
Assessment
Methods of assessment — the same structure in every delivery
Two summative assessments: a 60-point interim examination, sat in person at the start of the campus week, and the 40-point capstone project, submitted in writing and presented orally in the campus week. Formative quizzes support learning and are not graded.
| Component | What it involves | Weighting |
|---|---|---|
| Interim examination (summative) | Single-best-answer examination: 40 items at 1.5 points each, one hour, sat in person at the university’s Examination Centre on the Monday of the campus week, before campus teaching begins. At least 11 of 60 points are needed to be admitted to the final assessment. | 60 points |
| Capstone project (summative) | An individual, policy-informed analysis of a clinical case, allocated from an anonymised case bank or, where available, an anonymised case from the student’s own clinical experience, benchmarked against a stated European objective (2,000 words; 5–10 references in Vancouver style; up to 4 tables and 4 figures). The written project is submitted on the learning platform by 12:00 on the Wednesday of the campus week (25 points) and defended before a faculty panel on the Friday of the campus week (15 points). | 40 points |
| Formative self-assessment (not graded) | After each Saturday webinar: a formative quiz, with worked answers, for practice. Separate from the interim examination and the capstone project. | — |
Grading scale (European credit framework)
| Grade | Points |
|---|---|
| A · Excellent | 91–100 |
| B · Very good | 81–90 |
| C · Good | 71–80 |
| D · Satisfactory | 61–70 |
| E · Sufficient | 51–60 |
| FX · Not passed | 41–50 (one additional final assessment permitted) |
| F · Fail | 0–40 |
Reading list
Key references
Every session is anchored to named, dated and externally verifiable sources. Links open in a new tab.
European policy and law
- European Commission. EU Cardiovascular Health Plan (Safe Hearts Plan). COM(2025) 1024, 16 December 2025.
- European Commission. Gender Equality Strategy 2026–2030. Adopted 5 March 2026.
- Interinstitutional Proclamation on the European Pillar of Social Rights (2017/C 428/09), principle 16.
- European Commission. Europe’s Beating Cancer Plan. COM(2021) 44 final.
- Council Recommendation of 9 December 2022 on strengthening prevention through early detection: cancer screening (2022/C 473/01).
- European Commission. Union of Equality: Strategy for the Rights of Persons with Disabilities 2021–2030. COM(2021) 101 final.
- Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare.
- Regulation (EU) 2024/1689 — Artificial Intelligence Act.
- Regulation (EU) 2025/327 — European Health Data Space.
- Regulation (EU) 2021/2282 — health technology assessment.
Clinical guidelines and consensus
- Hickey M, et al. An empowerment model for managing menopause. Lancet 2024;403:947–957.
- Lambrinoudaki I, et al. Menopause, wellbeing and health: a care pathway from the European Menopause and Andropause Society. Maturitas 2022;163:1–14.
- NICE guideline NG23: Menopause — identification and management (updated November 2024).
- Maas AHEM, et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions. Eur Heart J 2021;42:967–984.
- Vogel B, et al. The Lancet women and cardiovascular disease Commission. Lancet 2021;397:2385–2438.
- Kanis JA, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2019;30:3–44.
- Kanis JA, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int 2020;31:1–12.
- NICE technology appraisal guidance TA1152: semaglutide in cardiovascular disease with overweight or obesity. May 2026.
8 · What changed this month
The living curriculum, in public
Guidance is watched for change; when a cornerstone guideline moves, the affected teaching is reviewed, re-signed and re-dated by a named clinician.
Each entry names the module, the change, the signer and the date. The list is read from the learning platform; where it cannot load, see the change log.
Register your interest
Selecting a button opens a pre-addressed email to enquiry@mdacumen.com. Add your details and send; we will confirm eligibility, the enrolment route and any fees.
Need further details? Please visit our contact page, or write to enquiry@mdacumen.com.
9 · Last editorial review: · Next scheduled refresh: .
© 2026 MD Acumen Ltd · Registered in England and Wales · Company no. 16538952 · ICO registration ZC105897